Endocrine Therapy Nonadherence and Discontinuation in Black and White Women

BACKGROUND: Differential use of endocrine therapy (ET) by race may contribute to breast cancer outcome disparities, but racial differences in ET behaviors are poorly understood. METHODS: Women aged 20–74 years with a first primary, stage I–III, hormone receptor–positive (HR+) breast cancer were incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheeler, Stephanie B, Spencer, Jennifer, Pinheiro, Laura C, Murphy, Caitlin C, Earp, Jo Anne, Carey, Lisa, Olshan, Andrew, Tse, Chiu Kit, Bell, Mary E, Weinberger, Morris, Reeder-Hayes, Katherine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510227/
https://www.ncbi.nlm.nih.gov/pubmed/30239824
http://dx.doi.org/10.1093/jnci/djy136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510227/
https://www.ncbi.nlm.nih.gov/pubmed/30239824
http://dx.doi.org/10.1093/jnci/djy136

Ejemplares similares